Policy Brief
⭐ 4.5
Education Policy and Cost–Benefit Analysis among Pharmaceutical Firms — 2020–2026 Trends
Abstract
This policy brief investigates “Education Policy and Cost–Benefit Analysis among Pharmaceutical Firms — 2020–2026 Trends” using a agent-based simulation. Through a behavioral lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.